526739 Stock Overview
Manufactures and sells gelatine and related products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Narmada Gelatines Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹359.75 |
| 52 Week High | ₹454.95 |
| 52 Week Low | ₹320.00 |
| Beta | 0.50 |
| 11 Month Change | 7.97% |
| 3 Month Change | -7.40% |
| 1 Year Change | -14.53% |
| 33 Year Change | 107.95% |
| 5 Year Change | 130.61% |
| Change since IPO | 1,269.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526739 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 6.7% | 1.5% | 2.0% |
| 1Y | -14.5% | 12.6% | 28.6% |
Return vs Industry: 526739 underperformed the Indian Chemicals industry which returned 11.8% over the past year.
Return vs Market: 526739 underperformed the Indian Market which returned 29.5% over the past year.
Price Volatility
| 526739 volatility | |
|---|---|
| 526739 Average Weekly Movement | 3.7% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 526739 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 526739's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 197 | Ashok Kapur | www.narmadagelatines.com |
Narmada Gelatines Limited manufactures and sells gelatine and related products in India and internationally. The company’s products include ossein and di-calcium phosphate. It serves food and beverage, pharmaceutical, photography, biomedical, personal care, and other technical industries.
Narmada Gelatines Limited Fundamentals Summary
| 526739 fundamental statistics | |
|---|---|
| Market cap | ₹2.18b |
| Earnings (TTM) | ₹161.40m |
| Revenue (TTM) | ₹1.88b |
13.5x
P/E Ratio1.2x
P/S RatioIs 526739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526739 income statement (TTM) | |
|---|---|
| Revenue | ₹1.88b |
| Cost of Revenue | ₹1.44b |
| Gross Profit | ₹432.76m |
| Other Expenses | ₹271.37m |
| Earnings | ₹161.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 26.68 |
| Gross Margin | 23.06% |
| Net Profit Margin | 8.60% |
| Debt/Equity Ratio | 19.3% |
How did 526739 perform over the long term?
See historical performance and comparison